Emergency Department-Initiated Buprenorphine Validation Network Trial

Recruiting

18 years - 99 years

All

Phase N/A

1 Location

Brief description of study

The purpose of this research study is to compare two versions of the same medication buprenorphine, (commonly known as Suboxone) used to treat opioid use disorder, in patients in the Emergency Department (ED). One form of the medication is a slow-release form of buprenorphine (CAM2038) that lasts for about 7 days and is given as a small injection, under the skin. The other medication is a pill or a film form of buprenorphine that you place under the tongue (sublingual buprenorphine).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: opioid use disorder
Age: 18 years - 99 years
Gender: All

Male or Female, age 18 or older Opiod user

Updated on 04 Aug 2024. Study ID: 842606

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Emergency Department-Initiated Buprenorphine Validation Network Trial

Brief description of study

Eligibility of study

Find a site

Interested in the study